Acute Renal Allograft Rejection
Acute Renal Allograft Rejection
Acute Renal Allograft Rejection
Correct
59% answered correctly
Explanation:
This patient is most likely experiencing acute renal allograft rejection, which is
predominantly a T-cell mediated response to antigens within the donor kidney.
The use of immunosuppression with calcineurin inhibitors (eg, tacrolimus) and
antiproliferative agents (eg, mycophenolate) markedly reduces the incidence of
acute rejection; however, it is still a risk. When it occurs it is most commonly within
the first 6 months following transplant.
Patients with acute rejection are usually asymptomatic, but they may have fever,
decreased urine output, or graft tenderness. The process is usually recognized by
acutely increased serum creatinine, often accompanied by proteinuria.
Diagnostic confirmation requires renal biopsy, which characteristically reveals
lymphocytic infiltration of the intima with inflammatory tubular disruption. Intimal
arteritis is often present as well. Acute rejection is mostly reversible, and
treatment involves the administration of high-dose intravenous glucocorticoids,
usually accompanied by increased dosing of the patient's maintenance
immunosuppression regimen to help prevent further episodes.
(Choice C) Pyelonephritis can affect a transplanted kidney and cause acute renal
dysfunction, but it is expected to cause symptoms (eg, fever, dysuria, pelvic pain)
and positive nitrates and/or leukocyte esterase on urinalysis.
Educational objective:
Acute renal allograft rejection is predominantly T-cell mediated and usually occurs
within the first 6 months following transplant. Affected patients typically experience
an asymptomatic rise in serum creatinine. The diagnosis is confirmed by renal
biopsy showing lymphocytic infiltration of the intima, and treatment is with high-
dose intravenous glucocorticoids.
Last updated:
Time spent: QID:4152
01/01/2024